Experience of surgical treatment of morbid obesity in a patient with hypercortisolism and primary hyperparathyroidism: prioritization
https://doi.org/10.14341/omet13143
Abstract
Morbid obesity is a pathology associated with a complex of metabolic disorders, type 2 diabetes mellitus, and cardiovascular diseases, leading to extremely negative health consequences, which necessitates a multidisciplinary approach. The presented clinical case is an example of a combination of primary (exogenous-constitutional) obesity with two other endocrine diseases, and it demonstrates the importance of determining the optimal treatment tactic for a patient with morbid obesity, taking into account his concomitant diseases. Step-by-step patient treatment was carried out by a team of therapeutic and surgical specialists
About the Authors
K. A. KomshilovaRussian Federation
Kseniya A. Komshilova, PhD
11 Dm. Ulyanova street, 117036 Moscow
Competing Interests:
None
V. R. Cheredanova
Russian Federation
Vikroriia R. Cheredanova
11 Dm. Ulyanova street, 117036 Moscow
Competing Interests:
None
E. V. Ershova
Russian Federation
Ekaterina V. Ershova, MD, PhD
11 Dm. Ulyanova street, 117036 Moscow
Competing Interests:
None
N. V. Mazurina
Russian Federation
Natalya V. Mazurina, MD, PhD
11 Dm. Ulyanova street, 117036 Moscow
Researcher ID: S-2312-2016
Competing Interests:
None
N. M. Platonova
Russian Federation
Nadezhda M. Platonova, MD, PhD
11 Dm. Ulyanova street, 117036 Moscow
Competing Interests:
None
D. G. Beltsevich
Russian Federation
Dmitry G. Beltsevich, MD, PhD
11 Dm. Ulyanova street, 117036 Moscow
Competing Interests:
None
M. Yu. Yukina
Russian Federation
Marina Yu. Yukina, MD, PhD
11 Dm. Ulyanova street, 117036 Moscow
Competing Interests:
None
E. A. Troshina
Russian Federation
Ekaterina A. Troshina, MD, PhD, professor
11 Dm. Ulyanova street, 117036 Moscow
Competing Interests:
None
References
1. Ammori BJ, MC Skarulis, H Soran, et al. Medical and surgical management of obesity and diabetes: what’s new? Diabetic Medicine: A Journal of the British Diabetic Association 37(2):203–10. doi: https://doi.org/10.1111/DME.14215
2. Eliashevich SO, Dadaeva VA, Drapkina OM. Losing and «maintaining» body weight is a well-known inequity in the prevention of chronic noncommunicable diseases. Russian Journal of Preventive Medicine. 2022;25(3):85-91. (In Russ.). doi: https://doi.org/10.17116/profmed20222503185
3. Bilezikian JP, Khan AA, Silverberg SJ, et al. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 37(11):2293–2314. doi: https://doi.org/10.1002/JBMR.4677
4. Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and Risks of Bariatric Surgery in Adults: A Review. JAMA. 2020;324(9):879–87. doi: https://doi.org/10.1001/JAMA.2020.12567
5. Khorgami Z, Shoar S, Saber AA, et al. Outcomes of Bariatric Surgery Versus Medical Management for Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Controlled Trials. Obesity Surgery. 2019;29(3):964–74. doi: https://doi.org/10.1007/S11695-018-3552-X
6. Bettini S, Belligoni A, Fabris R, Busetto L. Diet approach before and after bariatric surgery. Reviews in Endocrine & Metabolic Disorders. 2020;21(3):297–306. doi: https://doi.org/10.1007/S11154-020-09571-8
7. Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery Obesity Surgery 2023;33(1):3–14. doi: https://doi.org/10.1007/S11695-022-06332-1
8. Chevais A, Elfimova AR, Beltsevich DG. Primary bilateral macronodular adrenal hyperplasia: clinical and laboratory features. Problems of Endocrinology. 2023;69(3):58-67. (In Russ.) doi: https://doi.org/10.14341/probl13301
9. Chevais A, Elfimova AR, Derkatch DA, et all. Unilateral adrenalectomy for primary bilateral macronodular adrenal hyperplasia. Endocrine Surgery. 2023;17(1):20-29. (In Russ.) doi: https://doi.org/10.14341/serg12779
10. Chevais A. Sindrom Kushinga pri makronodulyarnoj dvustoronnej giperplazii kory` nadpochechnikov: ocenka e`ffektivnosti odnostoronnej adrenale`ktomii i immunogistoximicheskaya verifikaciya aberrantny`x i e`utopicheskix receptorov. dissertation Moskva; 2023. (In Russ).
11. Cusano NE, Cetani F. Normocalcemic primary hyperparathyroidism Archives of Endocrinology and Metabolism. 66(5):666–77. doi: https://doi.org/10.20945/2359-3997000000556
12. Minisola S, Arnold A, Belaya Z, et al. Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research. 2022;37(11):2315–29. doi: https://doi.org/10.1002/JBMR.4665
13. Dedov II, Mazurina NV, Ogneva NA, et al. Narusheniya metabolizma vitamina D pri ozhirenii. Obesity and metabolism. 2011;8(2):3-10. (In Russ.) doi: https://doi.org/10.14341/2071-8713-4946
14. Zhu CY, Sturgeon C, Yeh MW. Diagnosis and Management of Primary Hyperparathyroidism. JAMA. 2020;323(12):1186–87. doi: https://doi.org/10.1001/JAMA.2020.0538
15. Mamedova EO, Mokrysheva NG, Rozhinskaya LYa. Hereditary forms of primary hyperparathyroidism. Osteoporosis and Bone Diseases. 2018;21(2):23-29. (In Russ.) doi: https://doi.org/10.14341/osteo9877
Supplementary files
|
1. Figure 1. Photo of the patient before and after bariatric surgery. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(732KB)
|
Indexing metadata ▾ |
Review
For citations:
Komshilova K.A., Cheredanova V.R., Ershova E.V., Mazurina N.V., Platonova N.M., Beltsevich D.G., Yukina M.Yu., Troshina E.A. Experience of surgical treatment of morbid obesity in a patient with hypercortisolism and primary hyperparathyroidism: prioritization. Obesity and metabolism. 2024;21(4):405-411. (In Russ.) https://doi.org/10.14341/omet13143

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).